Forgot your password?

Forgot your username?

database > company
Vasonova
Medical Devices & Tech
1368 Bordeaux Drive, Suite 100
Sunnyvale, CA 94089
phone:408-738-7001
fax:408-738-7011
Symbol Private
Founded 2005
Employees
www.VasoNova.com
Research Sector Medical Devices & Tech
Summary Description
Leader in algorithm-based vascular navigation and measurement technology that has created, developed and commercialized an innovative vascular navigation system.
Management
Gary Wright, President and CEO; Gary Robinson, Vice President of Sales; Kim Tompkins, Vice President of Regulatory Affairs, Quality Assurance and Clinical Research and Corporate Compliance Officer; Wenkang Qi, PhD, Vice President of Engineering and R&D; Tina Cheng, Senior Director, Marketing and Business Development; Rosa Liu, Senior Director of Finance
Keywords
catheter guidance, catheter, ultrasound, EKG, drug delivery, PICC, peripherally inserted central catheters, Paul Molloy, CEO; Kim Tompkins, Vice President of Regulatory Affairs, Quality Assurance and Clinical Research and Corporate Compliance Officer; Tina Cheng, Senior Director, Marketing and Business Development; Rosa Liu, Senior Director of Finance

Comment | Printable Version | Modify profile |
Updated: Oct. 18, 2010

Description
Vasonova has invented a system (VPS-Vascular Positioning System) for placing PICC's, catheters threaded to the superior vena cava from the upper arm used for the administration of various drugs and therapies. Vasonova's system, combines intravascular ultrasound with EKG, enables clinicians to guide the catheter to the correct site 90% of the time on the first attempt, compared to 74% using traditional methods.
Products / Services
Vasonova's VPS combines intravascular ultrasound with EKG to enable the clinician to guide the catheter to the lower 1/3 of the superior vena cava at or near the caval-atrial junction at least 90% of the time on the first attempt. Vasonova has developed sophisticated algorithms that measure and analyze multiple physiologic signatures within the body to aid the clinician during catheter placement. The VPS system is not dependent on an isolated variable, such as a the P wave, used by clinicians in the past to place central venous catheters. VPS is the first true intravenous measurement technology that analyzes the body's physiologic changes so clinicians can confidently place a PICC. The technology can eventually be used to guide many other catheters such as Central Venous Catheters, Temporary Hemodialysis Catheters and Ports.
Technology / Differentiation
PICCs are typically placed "blindly". A nurse or physician measures the length of a catheter needed and cuts the excess. The catheter is inserted and a chest x-ray is taken to confirm if the tip of the catheter is in the lower third of the superior vena cava. If the catheter is not in the proper place the catheter is adjusted and another chest x-ray is taken to confirm placement. This will continue until the placement of the catheter tip is in the correct position. Improper placement of the PICC line may result in multiple chest x-rays, fragmented work flow, wasted dressing materials, overtime costs to the institution, increased patient length of stay, delayed administration of therapy, increased cost for the utilization of external PICC service companies after normal staff hours, multiple manipulations of the PICC which might introduce an infection, and patient discomfort and/or dissatisfaction with care.
Market / Customers
There are more than 7 million catheters placed in the US alone that could benefit from Vasonova's Vascular Positioning System Technology. The market for PICCs is in excess of the 3 million sold in the US and is growing at 17% per year.
Competitors / Substitutes / Alternatives
In the past 2 years, CR Bard has converted 50% of its PICC business to catheter guidance tchnology. Its system is comprised of a magnetic wire inserted into a catheter tip and an external device used to determine where the catheter is within the body. CR Bard has about 60% of the PICC market share.
Status
The VPS is a disruptive technology with the potential to change the way central venous catheters are placed by eliminating the need to guide the PICC using chest x-rays. Without the need for an x-ray, PICCs can be placed in the outpatient or homecare setting, reducing the total cost of care.